The University of Chicago Header Logo

Connection

Sangeeta Bhorade to Lung

This is a "connection" page, showing publications Sangeeta Bhorade has written about Lung.
Connection Strength

1.116
  1. The lung microbiome after lung transplantation. Expert Rev Respir Med. 2014 Apr; 8(2):221-31.
    View in: PubMed
    Score: 0.269
  2. Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
    View in: PubMed
    Score: 0.254
  3. Comparison of three tacrolimus-based immunosuppressive regimens in lung transplantation. Am J Transplant. 2003 Dec; 3(12):1570-5.
    View in: PubMed
    Score: 0.132
  4. Clinical relevance of lung-restricted antibodies in lung transplantation. Hum Immunol. 2019 Aug; 80(8):595-601.
    View in: PubMed
    Score: 0.096
  5. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
    View in: PubMed
    Score: 0.086
  6. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med. 2017 Aug 07; 214(8):2387-2404.
    View in: PubMed
    Score: 0.084
  7. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta. Am J Respir Cell Mol Biol. 2009 Sep; 41(3):332-8.
    View in: PubMed
    Score: 0.047
  8. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest. 2006 Sep; 130(3):847-54.
    View in: PubMed
    Score: 0.040
  9. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. J Heart Lung Transplant. 2005 Apr; 24(4):421-5.
    View in: PubMed
    Score: 0.036
  10. The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc. 2022 06; 19(6):916-924.
    View in: PubMed
    Score: 0.030
  11. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000 Dec; 19(12):1199-204.
    View in: PubMed
    Score: 0.027
  12. A novel p38 mitogen-activated protein kinase/Elk-1 transcription factor-dependent molecular mechanism underlying abnormal endothelial cell proliferation in plexogenic pulmonary arterial hypertension. J Biol Chem. 2013 Sep 06; 288(36):25701-25716.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.